Subtype
Gestational Trophoblastic Tumor
CI-CAN-00000928GTTExplore in graph →
Non-malignant8 active trials
Loading cancer entity…
Subtype
CI-CAN-00000928GTTExplore in graph →
Clinical trials
61 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01535053 | Dactinomycin or Methotrexate in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia | completed | Phase 3 | 57 | GOG FoundationNETWORK | 5 | Aug 12, 2022 | clinicaltrials |
| NCT01984099 | RCT on the Efficacy of Methotrexate for the Prevention of GTD | completed | Phase 3 | 99 | University of the PhilippinesOTHER | 1 | Apr 17, 2020 | clinicaltrials |
| NCT00003702 |
| Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia |
| completed |
| Phase 3 |
| 240 |
| Gynecologic Oncology GroupNETWORK |
| 1 |
| May 15, 2018 |
| clinicaltrials |
| NCT00058071 | Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Cancer | completed | Phase 3 | 100 | Gynecologic Oncology GroupNETWORK | 1 | Jul 9, 2013 | clinicaltrials |
Data updated 22 days agoSource updated Aug 12, 2022source: clinicaltrials